Akers Biosciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,577.90
4,427.20
2,115.10
2,960.90
3,354.70
1,665.60
Cost of Goods Sold (COGS) incl. D&A
2,172.40
1,433.80
1,187.50
1,254.20
2,577.20
1,709.40
Gross Income
1,405.40
2,993.40
927.60
1,706.70
777.50
43.80
SG&A Expense
3,216.10
6,197.50
10,143.30
5,035.40
7,391.30
8,511.60
EBIT
1,810.70
3,204.10
9,215.80
3,328.60
6,613.80
8,555.40
Unusual Expense
91.30
4.70
460.40
-
-
2,285.20
Non Operating Income/Expense
192.70
2.70
7.50
3.30
759.90
174.20
Pretax Income
1,526.80
3,127.20
9,581.30
3,303.50
7,366.30
10,849
Income Tax
-
-
269.30
-
-
-
Consolidated Net Income
1,526.80
3,127.20
9,311.90
3,303.50
7,366.30
10,849
Net Income
1,526.80
3,127.20
9,311.90
3,303.50
7,366.30
10,849
Net Income After Extraordinaries
1,526.80
3,127.20
9,311.90
3,303.50
7,366.30
10,849
Net Income Available to Common
1,526.80
3,143.00
9,311.90
3,303.50
7,366.30
10,849
EPS (Basic)
0.96
0.66
1.81
0.61
0.78
0.99
Basic Shares Outstanding
1,596.70
4,745.70
5,140.90
5,430.20
9,495.00
10,973.80
EPS (Diluted)
0.96
0.66
1.81
0.61
0.78
0.99
Diluted Shares Outstanding
1,596.70
4,745.70
5,140.90
5,430.20
9,495.00
10,973.80
EBITDA
1,456.30
2,854.70
8,915.80
3,042.50
6,363.90
8,320.90
Non-Operating Interest Income
-
69.60
102.50
21.80
7.40
165.80
Preferred Dividends
-
15.80
-
-
-
-
About Akers Biosciences
View Profile
